DiaMedica Therapeutics (DMAC) Other Non Operating Income (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Other Non Operating Income came in at $447000.0 in Q1 2026, up 0.9% year-on-year from $443000.0 in Q1 2025, and down 16.6% quarter-over-quarter from $536000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Other Non Operating Income (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $447000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 0.9% year-over-year to $447000.0 in Q1 2026; TTM through Mar 2026 was $963000.0, a 108.44% increase from a year earlier, with the FY2025 full-year figure at $515000.0, changed N/A from the prior year.
- Other Non Operating Income fell to $447000.0 in Q1 2026 per DMAC's latest filing, from $536000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $709000.0 in Q4 2023 and bottomed at -$21000.0 in Q3 2025.
- The 5-year median for Other Non Operating Income is $216000.0 (2022), against an average of $252411.8.
- Biggest YoY gain for Other Non Operating Income was 2721.05% in 2025; the steepest drop was 950.0% in 2025.
- Year by year, Other Non Operating Income stood at $216000.0 in 2022, then surged by 228.24% to $709000.0 in 2023, then slumped by 97.32% to $19000.0 in 2024, then jumped by 2721.05% to $536000.0 in 2025, then slipped by 16.6% to $447000.0 in 2026.
- Per Business Quant, the three latest DMAC Other Non Operating Income figures stand at $447000.0 (Q1 2026), $536000.0 (Q4 2025), and -$21000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | 536,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 443,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 597,000.00 |
| Dec 31, 2023 | 709,000.00 |
| Sep 30, 2023 | 693,000.00 |
| Jun 30, 2023 | 271,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 216,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 346,000.00 |
| Sep 30, 2021 | -27,000.00 |
| Jun 30, 2021 | 98,000.00 |